Updated on 2024/04/19

写真a

 
SAITO Yurika
 
Title
Assistant Professor
Date of Birth
1988

Research Areas

  • Life Science / Molecular biology

  • Life Science / Neurosurgery

  • Life Science / Tumor biology

Graduating School

  • Yamagata University, Faculty of Science

    2011.03, Graduated

Graduate School

  • Yamagata University, Graduate School, Division of Science and Engineering

    Master's Course, 2013.03, Completed

  • Yamagata University, Graduate School, Division of Science and Engineering

    Doctor's Course, 2017.03, Accomplished credits for doctoral program

 

Papers

  • The MDM2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells., International journal of molecular sciences, 25(7) , 2024.04

    Nakagawa-Saito Y, Mitobe Y, Togashi K, Suzuki S, Sugai A, Takenouchi S, Nakamura K, Sonoda Y, Kitanaka C, Okada M

    Multiple Authorship (Only Japanese)

  • HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny, International Journal of Molecular Sciences, 23(15) 8084, 2022.07

    Yurika Nakagawa Saito, Shinichi Saitoh, Yuta Mitobe, Asuka Sugai, Keita Togashi, Shuhei Suzuki, Chifumi Kitanaka, Masashi Okada

    Multiple Authorship (Only Japanese)

  • CEP-1347 Dually Targets MDM4 and PKC to Activate p53 and Inhibit the Growth of Uveal Melanoma Cells., Cancers, 16(1) , 2023.12

    Togashi K, Suzuki S, Mitobe Y, Nakagawa-Saito Y, Sugai A, Takenouchi S, Sugimoto M, Kitanaka C, Okada M

    Multiple Authorship (Only Japanese)

  • Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells., Cancers, 15(17) , 2023.08

    Mitobe Y, Suzuki S, Nakagawa-Saito Y, Togashi K, Sugai A, Sonoda Y, Kitanaka C, Okada M

    Multiple Authorship (Only Japanese)

  • The Novel MDM4 Inhibitor CEP-1347 Activates the p53 Pathway and Blocks Malignant Meningioma Growth In Vitro and In Vivo., Biomedicines, 11(7) , 2023.07

    Mitobe Y, Suzuki S, Nakagawa-Saito Y, Togashi K, Sugai A, Sonoda Y, Kitanaka C, Okada M

    Multiple Authorship (Only Japanese)

  • Domatinostat Targets the FOXM1-Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents., International journal of molecular sciences, 24(13) , 2023.06

    Nakagawa-Saito Y, Mitobe Y, Suzuki S, Togashi K, Sugai A, Kitanaka C, Okada M

    Multiple Authorship (Only Japanese)

  • Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to Temozolomide., Anticancer research, 43(3) 1131-1138, 2023.03

    Nakagawa-Saito Y, Mitobe Y, Togashi K, Suzuki S, Sugai A, Kitanaka C, Okada M

    Multiple Authorship (Only Japanese)

  • CEP-1347 Targets MDM4 Protein Expression to Activate p53 and Inhibit the Growth of Glioma Cells., Anticancer research, 42(10) 4727-4733, 2022.10

    Mitobe Y, Nakagawa-Saito Y, Togashi K, Suzuki S, Sugai A, Matsuda KI, Sonoda Y, Kitanaka C, Okada M

    Multiple Authorship (Only Japanese)

  • Inhibition of the Phospholipase Cε-c-Jun N-Terminal Kinase Axis Suppresses Glioma Stem Cell Properties., International journal of molecular sciences, 23(15) , 2022.08

    Okada M, Nakagawa-Saito Y, Mitobe Y, Sugai A, Togashi K, Suzuki S, Kitanaka C

    Multiple Authorship (Only Japanese)

  • The Sustained Release of Tafluprost with a Drug Delivery System Prevents the Axonal Injury-induced Loss of Retinal Ganglion Cells in Rats, Current Eye Research, 2020.09

    Kota Sato, Yurika Nakagawa, Kazuko Omodaka, Hiroyuki Asada, Shinobu Fujii, Kenji Masaki, Toru Nakazawa

    Multiple Authorship (Including Foreigners)

  • In vivo imaging of the light response in mouse retinal ganglion cells based on a neuronal activity-dependent promoter, Biochemical and Biophysical Research Communications, 2020.01

    Kosuke Fujita, Koji M Nishiguchi, Kota Sato, Yurika Nakagawa, Toru Nakazawa

    Multiple Authorship (Including Foreigners)

  • Reliable detection of low visual acuity in mice with pattern visually evoked potentials, Scientific Reports, 8 , 2018.10

    Naoyuki Tokashiki, Koji M. Nishiguchi, Kosuke Fujita, Kota Sato, Yurika Nakagawa, Toru Nakazawa

    Multiple Authorship (Including Foreigners)

  • Metabolomic changes in the mouse retina after optic nerve injury, Scientific Reports, 2018.08

    Kota Sato, Daisuke Saigusa, Ritsumi Saito, Amane Fujioka, Yurika Nakagawa, Koji M. Nishiguchi, Taiki Kokubun, Ikuko N. Motoike, Kazuichi Murayama, Kazuko Omodaka, Yukihiro Shiga, Akira Uruno, Seizo Ko...

    Multiple Authorship (Including Foreigners)

  • Ecel1 Knockdown With an AAV2-Mediated CRISPR/Cas9 System Promotes Optic Nerve Damage-Induced RGC Death in the Mouse Retina, Investigative ophthalmology & visual science, 2018.08

    Kota Sato, Yukihiro Shiga, Yurika Nakagawa, Kosuke Fujita, Koji M. Nishiguchi, Hiroshi Tawarayama, Namie Murayama, Shigeto Maekawa, Takeshi Yabana, Kazuko Omodaka, Shota Katayama, Qiwei Feng, Satoru T...

    Multiple Authorship (Including Foreigners)

  • Sustained release of Tafluprost with a newly developed drug delivery system protects retinal ganglion cells in rats after optic nerve transection, Investigative ophthalmology & visual science, 59(9) 6113, 2018.07

    Yurika Nakagawa, Kota Sato, Kazuko Omodaka, Toru Nakazawa

    Multiple Authorship (Including Foreigners)

  • Ecel 1 expression is promoted by damage to axonal flow and protects retinal ganglion cells after optic nerve crush in mice, Investigative ophthalmology & visual science, 59(9) 6138, 2018.07

    Kota Sato, Yurika Nakagawa, Hiroshi Tawarayama, Namie Murayama, Yukihiro Shiga, Kosuke Fujita, Koji M. Nishiguchi, Toru Nakazawa

    Multiple Authorship (Including Foreigners)

display all >>

Grant-in-Aid for Scientific Research

  • Grant-in-Aid for Scientific Research(C)，2023.04 - 2026.03